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N-nitroso compounds (NOCs) are suspected human
carcinogens and relevant in human exposure. NOCs also
induce micronuclei (MN) formation in vivo. Since lympho-
cytic MN represent a validated biomarker of human
cancer risk, establishing a link between NOC exposure and
MN frequency in humans and concurrently investigating
associated transcriptomic responses may provide crucial
information on underlying molecular mechanisms that
predispose to carcinogenicity. We used lymphocytes, from
adult females participating in the pan-European bio-
marker research project NewGeneris, as a surrogate tissue
for analysing such potentially carcinogenic gene expression
and MN formation events in target organs. To assess NOC
exposure, urine samples were analysed for marker nitros-
amines. NOC excretion levels and MN frequency were
subsequently linked to peripheral blood transcriptomics.
We demonstrated a significant association between MN
frequency and urinary NOCs (r 5 0.41, P 5 0.025) and
identified modifications in among others cytoskeleton
remodeling, cell cycle, apoptosis and survival, signal
transduction, immune response, G-protein signaling and
development pathways, which indicate a response to NOC-
induced genotoxicity. Moreover, we established a network
of genes, the most important ones of which include
FBXW7, BUB3, Caspase 2, Caspase 8, SMAD3, Huntingtin
and MGMT, which are involved in processes relevant in
carcinogenesis. The modified genetic processes and genes
found in this study may be of interest for future
investigations into the potential carcinogenic risk associ-
ated with NOC exposure in humans.
Introduction
Research on human exposure to N-nitroso compounds (NOCs)
has received much attention since it was shown in the 1960’s
that many NOCs are carcinogenic in rats (1). Most NOCs have
been classified as probable or possible human carcinogens by
the International Agency for Research on Cancer (2), and many
have been identified in foodstuffs, such as cured meat and beer,
particularly NOCs belonging to the nitrosamine class. Policy
measures to decrease the level of NOCs in these products have
led to a significantly lower dietary exposure (3). NOCs may
also be formed endogenously in the stomach and colon out of
the reaction between nitrate and amines or amides; this may
actually result in higher colonic exposure than caused by food-
borne NOC and may thus represent an important carcinogenic
risk (4,5). It remains difficult, however, to assess the actual
human cancer risk as human exposure is relatively low and
information on the possible (pre-) carcinogenic effects of
NOCs in humans is sparse. Although there have been
numerous reports on genotoxic and mutagenic properties of
NOCs in vitro in, for example, the sister chromatid exchange
assay and Ames test (6), this does not necessarily imply
a carcinogenic risk for intact humans, especially, since it is
difficult to determine the relationship between NOC-induced
genotoxicity or mutagenicity and the associated carcinogenicity
of these compounds (7). In several epidemiological studies,
human NOC exposure has been associated with increased
cancer risks of the stomach, esophagus, bladder and colon
(8,9), in particular in association with dietary intake of food
items with relatively high levels of NOC precursors or
nitrosating agents (4,10,11). There is, however, still no
consensus on whether NOCs actually are human carcinogens.
In an attempt to assess the potential carcinogenic effect of
NOCs in humans, with particular interest for NOC-induced
molecular mechanisms in the colon, we previously investigated
gene expression changes in the human colon adenocarcinoma
cell line Caco-2 (12). Indeed, we identified a large number of
NOC-modified molecular pathways involved in processes that
may contribute to the carcinogenic potential of NOCs in
humans, including pathways crucial in differentiation and
proliferation. Therefore, in the present study, we have
evaluated whether NOC exposure in human subjects induces
gene expression responses, which provide insights in their
possible human carcinogenicity. We have previously used
genomic analyses to improve our understanding of childhood
cancer risk associated with exposure to air pollution (13) and
have also investigated differences in gene expression levels in
adults subject to environmental burdens where associations
were found of gene expression with blood and urinary measures
of environmental carcinogens (14). In this study, we used
a similar approach by analysing the excretion of two marker
nitrosamines, i.e. N-nitrosodimethylamine (NDMA) and N-nitro-
sopiperidine (NPIP) (15), in urinary samples from pregnant
mothers participating in the Danish pilot study of the multidis-
ciplinary research project NewGeneris (www.newgeneris.org)
(16,17). Both nitrosamines are known to be carcinogenic in test
animals, may occur in several foodstuffs and can be formed
endogenously (18–20). Moreover, since NOCs cause micronuclei
(MN) formation in vivo and MN represent a validated predictive
biomarker of carcinogenic risk (21–23), MN analysis in
 The Author 2011. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society.
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peripheral lymphocytes provides an interesting marker to
associate with human NOC exposure. NOC excretion levels
and MN frequency were subsequently linked to peripheral blood
transcriptomics to gain mechanistic insight into the relationship




Potential study participants were identified from the pregnancy medical records
from the University Hospital of Copenhagen and the inclusion criteria were (i)
no chronic health complications, e.g. diabetes; (ii) .18 years; (iii) no private
commercial banking of cord blood; (iv) signed written informed consent and
(v) capacity to understand the informed consent. Eligible participants were (i)
non-smoking pregnant women, (ii) with no residential environmental tobacco
smoke exposure and (iii) who spent the majority of the time at home. The
Ethics Committee of the Capital Region of Denmark (Reference No. J. Nr. H-
KF-01-327603) and the Danish Data Protection Agency (Reference No. J. Nr.
2007-41-0415) reviewed and approved the studies prior to initiation. The study
population consisted of a subset of 32 pregnant women from a cross-sectional
biomonitoring study described previously (17), who were very homogenous in
age (32.4  3.7 years) and food intake. Further details on the characteristics of
the study population can also be found there.
Biological sample collection
Blood samples (50 ml) were drawn in heparinised tubes (Becton Dickinson,
Oxford, UK) by venipuncture in the morning hours, between 7 and 11 a.m. and
1–2 h before their planned caesarean section. The women had been fasting for
6 h. To stabilise RNA, 0.4 ml of whole blood was mixed with 1.2 ml
RNAlater (Ambion, Naerum, Denmark) and stored at 20C for the first 24 h
followed by a longer term storage at 80C for 3 years until use. Twenty-four
hour urine was collected in 2-l containers 1–5 days before child delivery and
10 g of NaOH was added to the urine to avoid degradation of NOC. Aliquots
of 50 ml were first stored at 20C (for 2 years) and subsequently at 80C
(6 months) until analysis.
Gas chromatography–mass spectrometry analysis of NDMA and NPIP in urine
NDMA and NPIP were determined by gas chromatography–mass spectrometry
(GC–MS) as previously described (24). In short, urine samples from donors
were thawed and extracted with dichloromethane (750 ll/14 ml urine). Then 1
ll of the extracted dichloromethane solution was injected into the GC–MS
system. Molecular ions were detected using a resolution of 3000 and
quantification was performed by a calibration curve for each of the two
nitrosamines, using standards dissolved in urine and extracted similarly to
adjust for a possible loss of nitrosamines during workup. Recovery of NOC was
40% (NDMA) and 90% (NPIP) (detection limit: 0.05 ng/ml urine). Total
urinary NOC levels (NDMA þ NPIP) were expressed in nanomoles per
millimole creatinine. Creatinine was measured by the Jaffe’s kinetic alkaline
picrate method. Creatinine and picric acid were obtained from Sigma–Aldrich
(Zwijndrecht, The Netherlands). Creatinine concentrations were determined
spectrophotometrically at a wavelength of 500 nm.
Cytokinesis-block micronucleus assay
MN frequencies per 1000 once-divided binucleated cells were analysed using
the cytokinesis-block micronucleus (CBMN) assay (25,26). Approximately 6 h
after collection from donors, whole blood cultures were initiated in duplicate.
At 72 h following phytohaemagglutinin stimulation, cells were harvested, fixed,
applied to slides and Giemsa stained as described before (17) and subsequently
scored (2000 binucleated cells per donor) using a light microscope at 400
magnification following the criteria for scoring MN set in the international
collaborative project on MN frequency in human populations (HUMN) (27).
For two subjects, no MN could be scored.
Microarray hybridisation and quality control
RNA was isolated from RNAlater-stabilised whole blood according to the
manufacturer’s protocol. Microarray hybridisation was performed as described
previously (12). In short, dye-labeled cRNA (Cy3) was synthesised following
the Agilent one-color Quick-Amp labeling protocol (Agilent Technologies,
Amstelveen, The Netherlands). Samples were hybridised on Agilent 4x44K
Whole Human Genome microarrays. After scanning the microarray slides,
using settings described before (12), bad and empty spots were flagged in
GenePix Pro (version 6.0; Molecular Devices, Sunnyvale, CA, USA). Quality
control was performed in R (version 2.10.1; The R Foundation for Statistical
Computing, Vienna, Austria). Quantile normalisation and data processing were
performed in ArrayTrack (version 3.4; NCTR, Jefferson, AR). Log2-trans-
formed spot intensities or ratios were used for further analyses. For two
subjects, microarrays did not pass quality control.
Statistics and microarray data analysis
Associations between urinary NOC excretion levels and MN frequencies were
investigated using Pearson’s correlation analysis after log2 transformation of
urinary excretion values to obtain a normally distributed data set. Normality of
the individual parameters was checked with the Kolmogorov–Smirnov test.
Only one outlier in the correlation analysis was identified, having an absolute
studentised residual .2 and a Cook’s distance .4/n and therefore excluded
(28). A P , 0.05 was considered significant.
ArrayTrack was used to find significantly modulated genes (two-tailed
Welch t-test, P , 0.05) between groups of subjects with the highest and lowest
total urinary NOC excretion or MN frequency. For this comparison, the highest
and lowest tertiles of total urinary NOC excretion (n 5 10 per tertile) or MN
frequency (n 5 9 per tertile) were selected since they displayed the most
significant difference (in contrast to quantiles, etc.). Differentially expressed
genes between the highest and lowest tertiles of either total urinary NOC
excretion or MN frequency were identified by combining a log ratio ranking
(absolute log2 ratio .0.5) with a non-stringent P cut-off of 5%, as suggested by
Shi et al. (29). Furthermore, only genes detected on the microarray and/or not
flagged as a bad spot in .70% of subjects were used in this analysis. Genes
were subsequently imported into MetaCore (GeneGo, San Diego, CA, USA)
to identify the involvement of differentially expressed genes in specific cellular
pathways. Pathways with a P , 0.05 were considered significantly modulated.
Gene expression data (log2-transformed spot intensities) were also used to
perform Spearman’s rank correlation analyses with levels of urinary NOC
excretion and MN frequency using the online Gene Expression Profile
Analysis Suite (GEPAS, http://gepas.bioinfo.cipf.es/). Only genes that were
detected on the microarray and/or not flagged as a bad spot in .70% of
subjects were used in the correlation analysis. Prior to correlation analysis,
missing values were imputed in GenePattern (http://www.broad.mit.edu/
cancer/software/genepattern/, version 3.1) by finding the k nearest neighbors
(k 5 15, Euclidean metric) and imputing missing elements by averaging non-
missing elements of its neighbors. Significantly correlating genes (P , 0.05)
were further analysed in MetaCore for pathway involvement. A gene network
based on a select number of genes was created in MetaCore using Dijkstra’s
shortest paths algorithm (30).
The gene expression data discussed in this publication have been deposited
in NCBI’s (National Center for Biotechnology Information) Gene Expression




To link NOC exposure with carcinogenic risk, we determined
whether there was a relationship between total urinary NOC
excretion (i.e. NDMA þ NPIP), as a marker of exposure, and
lymphocytic MN frequency as a biomarker of effect. We found
a statistically significant positive correlation between MN and
total urinary NOC excretion (r 5 0.41, P 5 0.025, Figure 1).
NOC exposure-related gene expression
We subsequently investigated transcriptomic responses in
lymphocytes to identify gene expression modulations that can
be related to NOC exposure, which may enable identifying
underlying molecular modes of action. Since women in the
outer tertiles of total urinary NOC excretion (n 5 10 per
tertile) displayed the most significant difference in excretion
levels (P , 0.01, results not shown), differentially expressed
genes in whole blood between the highest and lowest tertile of
total urinary NOC excretion were identified. Pathway analysis
with the differentially expressed genes revealed a list of
significantly modulated pathways (P , 0.05) between the
outer tertile groups (Table I). Differences in levels of NOC
excretion are mainly associated with modifications in amino
acid metabolism, apoptosis and survival, cell adhesion and
a few other signaling and metabolism pathways.
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To explore gene expression differences associated with NOC
exposure in more detail, we also analysed Spearman’s rank
correlations between individual gene expression data and total
urinary NOC values. Significantly correlating genes (P , 0.05)
were analysed for their involvement in biological pathways
using MetaCore (Table II). NOC excretion was again associated
with amino acid metabolism and apoptosis and survival. One
pathway involved in cell cycle regulation was also identified.
Most of the other modified pathways were involved in
cytoskeleton remodeling, development and G-protein signaling.
MN frequency-related gene expression
Similar to the analyses performed with urinary NOCs, we
associated differentially expressed genes with MN frequencies
in the highest versus lowest MN tertile (n 5 9 per tertile) and
performed a correlation analysis of MN levels and gene
expression data. As can be expected from the significant
correlation between urinary NOCs and MN frequency, there
was a strong overlap between subjects in the outer tertiles (i.e.
the highest and lowest tertile combined) of the NOC excretion
group (total outer tertile n 5 20) and MN frequency group
(total outer tertile n 5 18) of 13. Significantly modulated genes
between the highest and lowest tertiles or significantly
correlating genes (P ,0.05) were subsequently analysed in
MetaCore. In Tables III and IV, respectively, the results of the
tertile and correlation analyses are presented. The tertile
analysis only identified pathways related to carbohydrate and
lipid metabolism. Most of these pathways were also identified
in the MN frequency correlation analysis in addition to
pathways involved in development and transport and a few
other cytoskeleton remodeling, signal transduction, transcrip-
tion and metabolism-related pathways.
Comparison of Tables I and II with Tables III and IV shows
that three pathways are in common for the urinary NOC and
MN analyses, which are ‘Role of PKA (protein kinase A) in
cytoskeleton reorganisation’, ‘CREB (cAMP (cyclic AMP)
response element binding) pathway’ and ‘RXR (retinoid X
receptor)-dependent regulation of lipid metabolism via PPAR
(peroxisome proliferator-activated receptor), RAR (retinoic
acid receptor) and VDR (vitamin D receptor)’.
Fig. 1. Pearson’s correlation plot of log2-transformed total urinary NOC excretion versus MN frequency (per 1000 once-divided binuclear cells) in lymphocytes
(r 5 0.41, P 5 0.025, n 5 29).
Table I. GeneGO pathways significantly modulated by genes differentially regulated between subjects based on highest and lowest tertile of total urinary NOC
excretion
Process Pathways involved % genesa P-value
Amino acid metabolism Selenoamino acid metabolism 22 0.021
Glycine, serine, cysteine and threonine metabolism 12 0.026
Tyrosine metabolism p.2 (melanin) 15 0.043
Apoptosis and survival Endoplasmic reticulum stress response pathway 13 0.003
Regulation of apoptosis by mitochondrial proteins 11 0.035
Caspase cascade 11 0.035
Cytoplasmic/mitochondrial transport of proapoptotic
proteins Bid, Bmf and Bim
10 0.045
Blood coagulation Blood coagulation 14 0.016
Cell adhesion ECM remodeling 14 0.006
Plasmin signaling 14 0.016
Development Thrombopoetin signaling via JAK-STAT pathway 16 0.012
Immune response IL-2 activation and signaling pathway 10 0.045
Neurophysiological process GABAergic neurotransmission 20 0.026
Gamma-aminobutyrate (GABA) biosynthesis and
metabolism
15 0.043
Regulation of lipid metabolism RXR-dependent regulation of lipid metabolism via PPAR,
RAR and VDR
15 0.043
Sulfur metabolism Sulfur metabolism 14 0.050
Group sizes for tertiles were n 5 10.
aPercentage of significantly correlated genes compared to the total number of genes in the pathway (P , 0.05).
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Table II. GeneGO pathways significantly modulated by genes differentially regulated between subjects correlating with total urinary NOC excretion
Process Pathways involved % genesa P-value
Apoptosis and survival Apoptotic TNF-family pathways 32 0.003
Caspase cascade 29 0.024
Carbohydrate metabolism Glycolysis and gluconeogenesis p. 2/Human version 50 0.006
Cell cycle Regulation of G1/S transition (part 1) 27 0.046
Cytoskeleton remodeling ACM3 and ACM4 in keratinocyte migration 44 0.022
Role of PKA in cytoskeleton reorganisation 33 0.023
ESR1 action on cytoskeleton remodeling and cell migration 36 0.046
Development Activation of astroglial cells proliferation by ACM3 33 0.038
EGFR signaling via PIP3 36 0.046
G-protein signaling RhoA regulation pathway 44 0.000
Regulation of CDC42 activity 30 0.019
Regulation of RAC1 activity 28 0.030
Rac2 regulation pathway 30 0.039
Immune response Antigen presentation by MHC class II 57 0.008
Neurophysiological process Long-term depression in cerebellum 42 0.014
Netrin-1 in regulation of axon guidance 40 0.033
Glutamate regulation of dopamine D1A receptor signaling 36 0.046
Sulfur metabolism Sulfur metabolism 31 0.049
Transcription CREB pathway 33 0.038
Transport Alpha-2 adrenergic receptor regulation of ion channels 33 0.038
Group size for correlation analysis was n 5 30.
aPercentage of significantly correlated genes compared to the total number of genes in the pathway (P , 0.05).
Table III. GeneGO pathways significantly modulated by genes differentially regulated between subjects based on highest and lowest tertile of MN frequency
Process Pathways involved % genesa P-value
Carbohydrate metabolism Fructose metabolism 17 0.027
Glycolysis and gluconeogenesis 15 0.040
Regulation of lipid metabolism Phospholipid metabolism 38 0.006
RXR-dependent regulation of lipid metabolism via PPAR,
RAR and VDR
21 0.031
HETE and HPETE biosynthesis and metabolism 20 0.038
Plasmalogen biosynthesis 20 0.038
Group sizes for tertiles were n 5 9.
aPercentage of significantly correlated genes compared to the total number of genes in the pathway (P , 0.05).
Table IV. GeneGO pathways significantly modulated by genes differentially regulated between subjects correlating with MN frequency
Process Pathways involved % genesa P-value
Carbohydrate metabolism Fructose metabolism 17 0.025
Glycolysis and gluconeogenesis p. 1 20 0.036
Cytoskeleton remodeling Role of PKA in cytoskeleton reorganisation 22 0.011
Development Role of IL-8 in angiogenesis 14 0.028
Endothelin-1/EDNRA signaling 16 0.033
EDG3 signaling pathway 18 0.050
Heme metabolism Heme metabolism 19 0.018
Regulation of lipid metabolism Regulation of fatty acid synthase activity in hepatocytes 38 0.006
Phospholipid metabolism p.1 38 0.006
Stimulation of arachidonic acid production by ACM
receptors
14 0.028
RXR-dependent regulation of lipid metabolism via PPAR,
RAR and VDR
21 0.030
Inhibitory action of lipoxins and resolvin E1 on neutrophil
functions
20 0.036
Signal transduction PKA signaling 15 0.038
Steroid metabolism Cortisone biosynthesis and metabolism 29 0.044
Transcription CREB pathway 20 0.036
Transport Regulation of degradation of deltaF508 CFTR in CF 19 0.018
CFTR folding and maturation (norm and CF) 25 0.019
Regulation of CFTR activity (norm and CF) 17 0.025
Regulation of degradation of wt-CFTR 19 0.042
Group size for correlation analysis was n 5 28.
aPercentage of significantly correlated genes compared to the total number of genes in the pathway (P , 0.05).
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MN formation-associated gene network analysis
We recently presented a network analysis of a list of genes
related to MN formation, involved in processes such as spindle
assembly and DNA damage control, based on available
knowledge from literature (31). These genes were here
compared with the NOC excretion and MN frequency-related
gene sets and three genes (of a total of 27 genes and three gene
complexes) were found to overlap. One of these genes,
identified as FBWX7 (F-box and WD repeat domain contain-
ing 7), was found in the MN frequency-related gene set and
was represented in both the tertile comparison and the
correlation analysis. FBXW7 was significantly upregulated in
the upper tertile group compared to the lower tertile group
(log2 ratio: 0.8) and was positively correlated with MN
frequency. The other two genes were found in the NOC
excretion-related group and were identified as BUB3 (budding
uninhibited by benzimidazoles 3 homolog) and caspase 2.
BUB3 was significantly downregulated in the upper tertile
group compared to the lower tertile group (log2 ratio: 1.1)
and negatively correlated with NOC excretion levels (P ,
0.05). Caspase 2 was non-significantly upregulated in the upper
tertile group compared to the lower tertile group (log2 ratio:
1.8) but significantly and positively correlated with NOC
excretion (P , 0.05). MetaCore was subsequently used to
integrate FBXW7, BUB3 and caspase 2 into a network to
visualise their interactions. In Figure 2A, a, network analysis is
presented to find the shortest directed paths between genes of
interest. The network does not include all known interactions
of FBXW7, BUB3 and caspase 2 with other genes since this
would generate a too large network. The genes in this network
were checked for matches with significantly modulated or
correlated genes in the NOC excretion and MN frequency-
related gene sets and three matching genes were identified as
caspase 8, huntingtin (HTT) and SMAD3 (SMAD family
member 3), which were significantly correlated with NOC
excretion, thus increasing the potential relevance of the genes
in the network in relation to carcinogenicity. Since O6-
methylguanine-DNA methyltransferase (MGMT) is an impor-
tant gene involved in repair of alkyl adducts (18), this gene was
screened for significant modification or correlation with NOC
excretion and/or MN frequency and found to be significantly
upregulated in the MN frequency tertile analysis (log2 ratio:
0.5). Addition of MGMT to the network shows a close
interaction with genes already present in the network. In Figure
2B, an overview is presented of possible locations where these
seven genes and some of the modified pathways could play
a role in the relation between NOC exposure, repair, MN
formation and carcinogenesis.
Discussion
Analysing gene expression modulations associated with known
markers of exposure or well-validated phenotypic markers of
effect provide an innovative way of assessing environmental
health risks in chemically exposed populations of interest.
Microarray technology generates a large amount of informa-
tion, which not only makes it an interesting marker of effect but
also provides a complete overview of modified genes and
processes that can be helpful in understanding the molecular
basis of the effects induced by the compounds under
investigation. In the present study, we investigated the possible
carcinogenicity of NOCs in humans, using whole blood as
a surrogate tissue, by linking transcriptomics with urinary NOC
excretion and lymphocytic MN frequency as markers of
exposure and effect, respectively.
The significant positive association found between total
urinary NOC excretion levels and MN frequencies in
lymphocytes indicates a relation between NOC exposure and
the induction of genotoxicity (Figure 1). Other studies have
also implicated nitrosamines, and NDMA in particular, as
a likely contributor to human genotoxicity in surrogate tissues.
Formation of O6-methylguanine in human lymphocyte DNA,
for example, which is a pre-mutagenic lesion induced by
NDMA, was found in a large number of individuals not known
to have suffered excessive exposure to methylating agents (32).
When there are no evident exogenous sources of NOCs, such
as tobacco smoke, most of the genotoxicity induced by NOCs
can be attributed to endogenous formation (5), which is most
likely the case in this study population since environmental
tobacco smoke and ex-smoking did not significantly affect MN
levels, as previously published (17). The fact that in our study,
MN frequency was associated with exposure to NOCs points
towards a possible increased carcinogenic risk associated with
NOC exposure given that lymphocytic MN frequency is
considered a validated predictor of human carcinogenicity (21).
Nevertheless, some reservations should be made with regard to
the interpretation of MN scores in relation to in vivo exposures
as a direct marker of cancer risk (33). These reservations stem
mostly from the uncertainty about the origin of the MN formed
during the ex vivo proliferation of lymphocytes after in vivo
exposures to environmental genotoxins. In addition, the
relationship studied here between MN and NOC exposure or
gene expression could be different for MN originating from
chromosome breaks and those containing whole chromosomes
originating from chromosome malsegregation, which could be
distinguished in future studies using centromere probes. It also
important to consider the influence of background variables
that affect MN formation, such as age and nutritional status, but
these were homogenously distributed in this study population
as published previously (17) and therefore not likely to have
been of great influence. All in all, these results provide further
prove that nitrosamines pose a genotoxic risk to humans, which
may also contribute to the carcinogenic process.
The relationship between NOC exposure and genotoxicity
was further substantiated by establishing the transcriptomic
response associated with exposure to NOCs in lymphocytes.
Two separate analyses were performed, one focusing on the
comparison of subjects between the higher and lower tertile of
NOC excretion as a marker of exposure (Table I) and one
focusing on genes significantly correlated with NOC excretion
across all subjects (Table II). The first analysis allows for the
identification of the strongest effects between high- and low-
exposure groups while the correlation analysis may capture
more subtle effects since all genes, regardless of log2 ratio or
significance level, are used. Associations with several apopto-
sis and survival pathways were identified in both analyses
indicating that cell survival is affected by NOCs in humans. A
closer examination of the genes involved in these pathways
revealed that several pro-apoptotic genes were upregulated in
the upper exposure tertile of subjects thus indicating that higher
NOC exposure may be related with an increase in apoptosis.
This may demonstrate a direct consequence of the genotoxic
potency of these compounds. Although in vitro exposure of
cultured cells requires high millimolar concentrations of NOCs
to induce DNA damage or apoptosis (12,34,35), human
lymphocytes become apoptotic at micromolar NOC
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Fig. 2. (A) Shortest paths network developed in MetaCore based on genes related to FBXW7, BUB3 and caspase 2 shown in blue circles. Ellipses indicate
additional genes associated with urinary NOC excretion (in red, i.e. caspase 8, huntingtin and SMAD3) and MN frequency (in blue, i.e. MGMT). Exposure to NOC
resulting in DNA damage is indicated by ‘E’ and the DNA repair process by ‘R’. Detailed information on the symbols can be found at http://www.genego.com/pdf/
MC_legend.pdf. (B) Possible locations are shown for the involvement of the most important genes in the network analysis and some of the modified pathways
presented in Tables I–IV, in the route from NOC exposure to repair or other outcomes, such as apoptosis, MN formation and carcinogenesis.
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concentrations, which are physiologically more relevant (22).
This may be related to a relatively high rate of cytochrome
P450 (CYP)-catalysed NOC metabolism in lymphocytes (36).
Within this respect, it is interesting to note that apoptosis could
also be measured in the CBMN assay in ‘cytome’ mode
(26,37), which may be a valuable addition to future studies.
The analyses also revealed a cell cycle regulation pathway to
be associated with NOC excretion (Table II) in addition to
several pathways involved in cell adhesion and cytoskeleton
remodeling (Tables I and II). These are often linked with the
cell cycle regulation and apoptosis process, providing further
evidence for NOC-induced genotoxicity since DNA damage,
and in particular MN formation, affects the progression of the
cell cycle (38). The modifications in apoptosis- and cell cycle-
related pathways associated with NOC excretion, in addition to
the relation found with MN frequency, indicate that NOC
exposure levels found in humans at daily life conditions may
contribute to the carcinogenic process.
A relatively large number of pathways appear involved in
development and G-protein signaling processes. These pathways
are of interest since they involve signaling cascades that are
important in the regulation of differentiation and cell proliferation.
Signaling pathways that were found to be modulated were
implicated in the JAK-STAT signaling cascade and epidermal
growth factor receptor (EGFR) signaling and regulation of
a number of Rho GTPases. All these pathways play important
roles in cell growth, differentiation, cell death, DNA synthesis and
cell proliferation, which are crucial in cancer cell development
(39–41). These modifications may also be relevant with regard to
the NewGeneris objective of identifying prenatal exposures that
possibly influence the development of childhood cancer,
especially since NDMA can cross the placental barrier, thereby
leading to fetal exposure (16,42). In relation to this, the pathways
belonging to neurophysiological processes could be important in
neural tube defects that arise during fetal development since this
has been associated with NOC exposure (43). Other pathways
related to NOC excretion include a number of amino acid
metabolism pathways, which can probably be attributed to
translation-associated protein synthesis, and two immune re-
sponse pathways that are indicative of immunomodulation and
could be relevant in light of the immunosuppressive effects
described for NOCs in rodents (44).
Similar tertile and correlation analyses on gene expressions
changes and in relation to MN frequencies were performed to
investigate whether MN frequency itself was associated with
pathways of interest. In the tertile comparison analysis (Table
III), only pathways belonging to two cellular processes, i.e.
carbohydrate and lipid metabolism, were identified. Most of
these pathways were also identified in the correlation analysis
(Table IV) and they may be related to three other modified
pathways that are more easily interpreted with regard to MN
levels, which are the cytoskeleton remodeling pathway
describing the role of PKA, the PKA signal transduction
pathway itself and the CREB transcription pathway. PKA is
dependent on the level of cAMP in the cell, and both cAMP
and PKA have been implicated in MN formation in blood cells
(45). Moreover, PKA signaling plays an important role in the
regulation of glycogen, glucose and lipid metabolism with
CREB being an important downstream transcription factor
target of PKA (46).
A few developmental pathways involving interleukin 8 (IL-8),
endothelin receptor type A (EDNRA) and sphingosine-1-
phosphate receptor 3 (EDG3) were also identified and are of
special interest since they are all involved in angiogenesis
(47–49). The relevance of the transport pathways involving the
cystic fibrosis transmembrane conductance regulator (CFTR),
which functions as a chloride channel and controls the regulation
of transport pathways, is difficult to assess.
It is interesting that two of the three overlapping pathways
between NOC excretion and MN frequency are associated with
PKA and CREB signaling, which are implicated in MN
formation as discussed above, and may therefore represent an
intermediate mechanism in the link between NOC exposure
and MN formation. The continuum between exposure markers,
effect markers and disease and the identification of marker-
associated transcriptomic responses presents the possibility of
using gene expression modifications as mechanistic bio-
markers, especially if similar transcriptomic modifications are
found in the disease. This constitutes the Meet-in-the-Middle
concept as proposed by Vineis and Perera (50). It is therefore
especially interesting that the CREB pathway is now being
recognised as an important player in human cancer (51).
Recently, we published a transcriptomic network analysis
of MN formation-related genes based on available peer-
reviewed literature (31). In the present study, the genes
included in this previously published network were screened
for matches with both the NOC excretion- and the MN
frequency-associated expression sets. Three genes were found
to match and a network dedicated to find the shortest paths
between these genes was created (Figure 2A). As could be
expected, FBXW7, which was identified in the MN frequency
related gene set, is an important regulator in cell cycle and
DNA damage processes but also in aneuploidy and NOTCH
signaling (Table V) which is intimately linked with MN
formation (52). BUB3 and caspase 2, which were both
identified in the NOC excretion related gene set, are mostly
involved in cell cycle regulation and apoptosis and DNA
damage, respectively. More specifically, BUB3 is an essential
Table V. Biological processes regulated by FBXW7, BUB3 and caspase 2
Genes in MN frequency-related gene set Genes in total urinary NOC excretion-related gene set
FBXW7 BUB3 Caspase 2
Aneuploidy Cell cycle Apoptosis and survival
Cell cycle Mitotic cell cycle checkpoint DNA damage




Information on genes was obtained from NCBI (http://www.ncbi.nlm.nih.gov/sites/entrez?db5gene).
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component of the spindle checkpoint pathway and defects in
BUB genes are known to result in increased MN formation
(53). Within this respect, the negative correlation of BUB3
with NOC excretion levels supports the association between
NOC excretion and MN formation. FBXW7 and caspase 2 are
also implicated in the neoplastic process, stressing their
importance in relation to MN formation-associated carcino-
genic risk. Although FBXW7, BUB3 and caspase 2 are not
directly linked with each other in the network, they have
many upstream and downstream genes in common all of
which are important in the processes described in Table V.
The network was subsequently screened for additional
matches with the gene sets used in this study and three more
genes (caspase 8, HTT and SMAD3) were found to be present
in the gene set correlating with NOC excretion. All three
genes had direct interactions with BUB3 or caspase 2 (Figure
2A) and were involved in processes presented in Table V,
particularly apoptosis, cell cycle, DNA damage and neo-
plasm/carcinoma formation. MGMT was added separately to
this network since it is one of the most important DNA repair
enzymes involved in repairing alkyl adducts and because it
was found to be significantly up regulated in the MN
frequency tertile analysis. As could be expected, MGMT
interacts with the genes already present, including p53. The
network and these seven genes in particular are thus likely to
influence each other in response to NOC exposure and/or MN
formation. The network as such presents a transcriptomic
interactome that integrates gene expression modifications in
response to NOC exposure, MGMT-mediated repair and MN
formation. An overview of where these genes and some of the
modified pathways could be implicated in the route from
exposure to disease is presented in Figure 2B.
Since this is one of the first studies focused on identifying gene
expression modifications in surrogate tissue, further research is
needed to validate these results on a larger scale and possibly add
other relevant genes or processes to the list. This could be done by
screening large cohorts for similar expression profiles of these
specific genes in relation to MN frequency and NOC exposure. It
may be recommended to screen the gene expression profile in
lymphocytes alone, instead of whole blood. Although the basal
gene expression profiles of lymphocytes and whole blood is
known to show considerable overlap, the presence of reticulo-
cytes in whole blood introduces more variation, causing small
gene expression changes to be missed (54). However, whole
blood does have the advantage of immediate RNA stabilisation
after blood withdrawal, in contrast to the time-consuming
procedure required for lymphocyte isolation. Future validation
studies might also benefit from measuring NOC-induced DNA
adducts in relation to MN frequency and using the CBMN assay
in cytome mode to associate other effect markers with NOC
exposure, such as MN with/without centromere signals, nucle-
oplasmic bridges, nuclear buds, cell death (necrosis or apoptosis)
and nuclear division rate (26,37). The effects that we observed in
whole blood may be of relevance for molecular events in target
tissues exposed to NOCs, such as the gastro-intestinal tract or the
liver, which would normally be difficult to investigate due to their
inaccessibility. Although it is important to note that extrapolation
of results found in surrogate tissues to target tissues should be
done with caution, blood transcriptomics are known to reflect
effects induced in target tissue (55).
In summary, we have for the first time found a link between
urinary excretion of NOCs by individuals under daily life
circumstances and lymphocytic MN frequency as a marker of
effect. Gene expression changes associated with both markers
revealed modifications in pathways, which indicate molecular
responses related to genotoxicity and carcinogenicity. Our data
support a possible role of NOC exposure, through the diet or as
a result of endogenous nitrosation processes, in the de-
velopment of human cancer. Furthermore, the genetic pro-
cesses and genes found to be modified in this study may be of
relevance in future investigations into NOC-associated carci-
nogenicity in humans.
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